Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 229

    1.

    Combined effects of hyperglycemic conditions and HIV-1 Nef: a potential model for induced HIV neuropathogenesis.

    Acheampong EA, Roschel C, Mukhtar M, Srinivasan A, Rafi M, Pomerantz RJ, Parveen Z.

    Virol J. 2009 Oct 30;6:183.PMID: 19878567 [PubMed - in process]Related articlesFree article

    2.

    The challenge of finding a cure for HIV infection.

    Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ.

    Science. 2009 Mar 6;323(5919):1304-7. Review.PMID: 19265012 [PubMed - indexed for MEDLINE]Related articles

    3.

    Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity.

    Owe-Young R, Webster NL, Mukhtar M, Pomerantz RJ, Smythe G, Walker D, Armati PJ, Crowe SM, Brew BJ.

    J Neurochem. 2008 May;105(4):1346-57. Epub 2008 Jan 21.PMID: 18221377 [PubMed - indexed for MEDLINE]Related articles

    4.

    Antiviral potentials of medicinal plants.

    Mukhtar M, Arshad M, Ahmad M, Pomerantz RJ, Wigdahl B, Parveen Z.

    Virus Res. 2008 Feb;131(2):111-20. Epub 2007 Nov 5. Review.PMID: 17981353 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pentoxifylline suppresses transduction by HIV-1-based vectors.

    Smith JA, Nunnari G, Preuss M, Pomerantz RJ, Daniel R.

    Intervirology. 2007;50(5):377-86. Epub 2007 Oct 15.PMID: 17938572 [PubMed - indexed for MEDLINE]Related articles

    6.

    Hide-and-seek: the challenge of viral persistence in HIV-1 infection.

    Geeraert L, Kraus G, Pomerantz RJ.

    Annu Rev Med. 2008;59:487-501. Review.PMID: 17845138 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of highly active antiretroviral therapy on HIV-1-associated oral complications.

    Parveen Z, Acheampong E, Pomerantz RJ, Jacobson JM, Wigdahl B, Mukhtar M.

    Curr HIV Res. 2007 May;5(3):281-92. Review.PMID: 17504170 [PubMed - indexed for MEDLINE]Related articles

    8.

    Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.

    McKenna PM, Koser ML, Carlson KR, Montefiori DC, Letvin NL, Papaneri AB, Pomerantz RJ, Dietzschold B, Silvera P, McGettigan JP, Schnell MJ.

    J Infect Dis. 2007 Apr 1;195(7):980-8. Epub 2007 Feb 20.PMID: 17330788 [PubMed - indexed for MEDLINE]Related articles

    9.

    HIV-1 Vpr potently induces programmed cell death in the CNS in vivo.

    Cheng X, Mukhtar M, Acheampong EA, Srinivasan A, Rafi M, Pomerantz RJ, Parveen Z.

    DNA Cell Biol. 2007 Feb;26(2):116-31. Erratum in: DNA Cell Biol. 2007 Mar;26(3):192. Cheng, Xiandong [corrected to Cheng, Xiaodong]. PMID: 17328670 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitro.

    Acheampong E, Parveen Z, Mengistu A, Ngoubilly N, Wigdahl B, Lossinsky AS, Pomerantz RJ, Mukhtar M.

    J Virol. 2007 Feb;81(3):1492-501. Epub 2006 Nov 15.PMID: 17108035 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Mutation of the Rev-binding loop in the human immunodeficiency virus 1 leader causes a replication defect characterized by altered RNA trafficking and packaging.

    Greatorex JS, Palmer EA, Pomerantz RJ, Dangerfield JA, Lever AM.

    J Gen Virol. 2006 Oct;87(Pt 10):3039-44.PMID: 16963763 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Inhibition of endogenous reverse transcription of human and nonhuman primate lentiviruses: potential for development of lentivirucides.

    Argyris EG, Dornadula G, Nunnari G, Acheampong E, Zhang C, Mehlman K, Pomerantz RJ, Zhang H.

    Virology. 2006 Sep 30;353(2):482-90. Epub 2006 Jul 21.PMID: 16859727 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Rabies virus glycoprotein as a carrier for anthrax protective antigen.

    Smith ME, Koser M, Xiao S, Siler C, McGettigan JP, Calkins C, Pomerantz RJ, Dietzschold B, Schnell MJ.

    Virology. 2006 Sep 30;353(2):344-56. Epub 2006 Jul 3.PMID: 16820183 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects.

    Dave RS, McGettigan JP, Qureshi T, Schnell MJ, Nunnari G, Pomerantz RJ.

    Virology. 2006 May 10;348(2):489-97. Epub 2006 Feb 9.PMID: 16480752 [PubMed - indexed for MEDLINE]Related articles

    15.

    Anti-HIV-1 microbicides -- 'chemical condoms' designed to limit the scourge of the HIV-1 pandemic.

    Scholand SJ, DeSimone JA, Pomerantz RJ.

    Curr Pharm Des. 2005;11(29):3747-56. Review.PMID: 16305509 [PubMed - indexed for MEDLINE]Related articles

    16.

    IL-7 as a potential therapy for HIV-1-infected individuals.

    Nunnari G, Pomerantz RJ.

    Expert Opin Biol Ther. 2005 Nov;5(11):1421-6. Review.PMID: 16255646 [PubMed - indexed for MEDLINE]Related articles

    17.

    T-Cells and excitotoxicity: HIV-1 and other neurodegenerative disorders.

    Mukhtar M, Acheampong E, Parveen Z, Pomerantz RJ.

    Neuromolecular Med. 2005;7(3):265-73. Review.PMID: 16247186 [PubMed - indexed for MEDLINE]Related articles

    18.

    Seminal reservoirs during an HIV type 1 eradication trial.

    Nunnari G, Leto D, Sullivan J, Xu Y, Mehlman KE, Kulkosky J, Pomerantz RJ.

    AIDS Res Hum Retroviruses. 2005 Sep;21(9):768-75.PMID: 16218800 [PubMed - indexed for MEDLINE]Related articles

    19.

    Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infection.

    Nunnari G, Xu Y, Acheampong EA, Fang J, Daniel R, Zhang C, Zhang H, Mukhtar M, Pomerantz RJ.

    J Neurovirol. 2005 Aug;11(4):319-28.PMID: 16162475 [PubMed - indexed for MEDLINE]Related articles

    20.

    HIV type 1 cervicovaginal reservoirs in the era of HAART.

    Nunnari G, Sullivan J, Xu Y, Nyirjesy P, Kulkosky J, Cavert W, Frank I, Pomerantz RJ.

    AIDS Res Hum Retroviruses. 2005 Aug;21(8):714-8.PMID: 16131311 [PubMed - indexed for MEDLINE]Related articles

    21.

    Attenuation of HIV-1 infection by other microbial agents.

    Kannangara S, DeSimone JA, Pomerantz RJ.

    J Infect Dis. 2005 Sep 15;192(6):1003-9. Epub 2005 Aug 12. Review.PMID: 16107952 [PubMed - indexed for MEDLINE]Related articles

    22.

    Retroviruses and opportunistic infections--eighth annual conference.

    Mukhtar M, Pomerantz RJ.

    IDrugs. 2001 May;4(5):515-7.PMID: 16012887 [PubMed]Related articles

    23.

    Antiretroviral therapy in the developing world.

    Chulamokha L, DeSimone JA, Pomerantz RJ.

    J Neurovirol. 2005;11 Suppl 1:76-80. Review. No abstract available. PMID: 15960241 [PubMed - indexed for MEDLINE]Related articles

    24.

    AIDS Vaccine 2001. Advances in AIDS research.

    Mukhtar M, Parveen Z, Pomerantz RJ.

    IDrugs. 2001 Oct;4(10):1144-6. No abstract available. PMID: 15957080 [PubMed]Related articles

    25.

    Molecular interactions of human immunodeficiency virus type 1 with primary human oral keratinocytes.

    Acheampong EA, Parveen Z, Muthoga LW, Wasmuth-Peroud V, Kalayeh M, Bashir A, Diecidue R, Mukhtar M, Pomerantz RJ.

    J Virol. 2005 Jul;79(13):8440-53.PMID: 15956588 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Current status of gene therapy strategies to treat HIV/AIDS.

    Strayer DS, Akkina R, Bunnell BA, Dropulic B, Planelles V, Pomerantz RJ, Rossi JJ, Zaia JA.

    Mol Ther. 2005 Jun;11(6):823-42. Review.PMID: 15922953 [PubMed - indexed for MEDLINE]Related articles

    27.

    The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes.

    Fang J, Acheampong E, Dave R, Wang F, Mukhtar M, Pomerantz RJ.

    Virology. 2005 Jun 5;336(2):299-307.PMID: 15892970 [PubMed - indexed for MEDLINE]Related articles

    28.

    ATM: HIV-1's Achilles heel?

    Daniel R, Pomerantz RJ.

    Nat Cell Biol. 2005 May;7(5):452-3. No abstract available. PMID: 15867928 [PubMed - indexed for MEDLINE]Related articles

    29.

    Down-modulation of the CXCR4 co-receptor by intracellular expression of a single chain variable fragment (SFv) inhibits HIV-1 entry into primary human brain microvascular endothelial cells and post-mitotic neurons.

    Mukhtar M, Acheampong E, Khan MA, Bouhamdan M, Pomerantz RJ.

    Brain Res Mol Brain Res. 2005 Apr 27;135(1-2):48-57.PMID: 15857668 [PubMed - indexed for MEDLINE]Related articles

    30.

    Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines.

    Nunnari G, Argyris E, Fang J, Mehlman KE, Pomerantz RJ, Daniel R.

    Virology. 2005 May 10;335(2):177-84.PMID: 15840517 [PubMed - indexed for MEDLINE]Related articles

    31.

    Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases.

    Acheampong EA, Parveen Z, Muthoga LW, Kalayeh M, Mukhtar M, Pomerantz RJ.

    J Virol. 2005 Apr;79(7):4257-69.PMID: 15767427 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathways.

    Chen W, Tang Z, Fortina P, Patel P, Addya S, Surrey S, Acheampong EA, Mukhtar M, Pomerantz RJ.

    Virology. 2005 Mar 30;334(1):59-73.PMID: 15749123 [PubMed - indexed for MEDLINE]Related articles

    33.

    Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells.

    Daniel R, Marusich E, Argyris E, Zhao RY, Skalka AM, Pomerantz RJ.

    J Virol. 2005 Feb;79(4):2058-65.PMID: 15681408 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Spleen necrosis virus-based vector delivery of anti-HIV-1 genes potently protects human hematopoietic cells from HIV-1 infection.

    Marusich EI, Parveen Z, Strayer D, Mukhtar M, Dornburg RC, Pomerantz RJ.

    Virology. 2005 Feb 5;332(1):258-71.PMID: 15661158 [PubMed - indexed for MEDLINE]Related articles

    35.

    IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.

    Wang FX, Xu Y, Sullivan J, Souder E, Argyris EG, Acheampong EA, Fisher J, Sierra M, Thomson MM, Najera R, Frank I, Kulkosky J, Pomerantz RJ, Nunnari G.

    J Clin Invest. 2005 Jan;115(1):128-37.PMID: 15630452 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    RNA interference:a potential novel therapeutic combating HIV-1 in the central nervous system.

    Pomerantz RJ.

    Arch Immunol Ther Exp (Warsz). 2004 Nov-Dec;52(6):401-9. Review.PMID: 15577741 [PubMed - indexed for MEDLINE]Related articles

    37.

    The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity.

    Argyris EG, Kulkosky J, Meyer ME, Xu Y, Mukhtar M, Pomerantz RJ, Williams KJ.

    Virology. 2004 Dec 20;330(2):481-6.PMID: 15567441 [PubMed - indexed for MEDLINE]Related articles

    38.

    A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.

    Fang J, Kubota S, Yang B, Zhou N, Zhang H, Godbout R, Pomerantz RJ.

    Virology. 2004 Dec 20;330(2):471-80.PMID: 15567440 [PubMed - indexed for MEDLINE]Related articles

    40.

    Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque.

    McKenna PM, Aye PP, Dietzschold B, Montefiori DC, Martin LN, Marx PA, Pomerantz RJ, Lackner A, Schnell MJ.

    J Virol. 2004 Dec;78(24):13455-9.PMID: 15564456 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Ludwik Hirszfeld Memorial Lecture: HIV-1 reservoirs: major molecular obstacles to viral eradication.

    Pomerantz RJ.

    Arch Immunol Ther Exp (Warsz). 2004 Sep-Oct;52(5):297-306. Review.PMID: 15507870 [PubMed - indexed for MEDLINE]Related articles

    42.

    Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.

    Zhou N, Fang J, Mukhtar M, Acheampong E, Pomerantz RJ.

    Gene Ther. 2004 Dec;11(23):1703-12.PMID: 15306840 [PubMed - indexed for MEDLINE]Related articles

    43.

    Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.

    Cordelier P, Kulkowsky JW, Ko C, Matskevitch AA, McKee HJ, Rossi JJ, Bouhamdan M, Pomerantz RJ, Kari G, Strayer DS.

    Gene Ther. 2004 Nov;11(22):1627-37.PMID: 15295615 [PubMed - indexed for MEDLINE]Related articles

    44.

    Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agents.

    Kulkosky J, Sullivan J, Xu Y, Souder E, Hamer DH, Pomerantz RJ.

    AIDS Res Hum Retroviruses. 2004 May;20(5):497-505.PMID: 15186524 [PubMed - indexed for MEDLINE]Related articles

    45.

    Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: construction of a new generation of spleen necrosis virus-derived retroviral vectors.

    Parveen Z, Mukhtar M, Goodrich A, Acheampong E, Dornburg R, Pomerantz RJ.

    J Virol. 2004 Jun;78(12):6480-8.PMID: 15163741 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Effects of HIV-1 Vpr on neuroinvasion and neuropathogenesis.

    Pomerantz RJ.

    DNA Cell Biol. 2004 Apr;23(4):227-38. Review.PMID: 15142380 [PubMed - indexed for MEDLINE]Related articles

    47.

    HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host.

    Argyris EG, Pomerantz RJ.

    Trends Microbiol. 2004 Apr;12(4):145-8. No abstract available. PMID: 15116720 [PubMed - indexed for MEDLINE]Related articles

    48.

    HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy.

    Xu Y, Kulkosky J, Acheampong E, Nunnari G, Sullivan J, Pomerantz RJ.

    Proc Natl Acad Sci U S A. 2004 May 4;101(18):7070-5. Epub 2004 Apr 21.PMID: 15103018 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).

    Vogler MA, Teppler H, Gelman R, Valentine F, Lederman MM, Pomerantz RJ, Pollard RB, Cherng DW, Gonzalez CJ, Squires KE, Frank I, Mildvan D, Mahon LF, Schock B; AIDS Clinical Trials Group 248 Study Team.

    J Acquir Immune Defic Syndr. 2004 May 1;36(1):576-87.PMID: 15097300 [PubMed - indexed for MEDLINE]Related articles

    50.

    Spliced spleen necrosis virus vector RNA is not encapsidated: implications for retroviral replication and vector design.

    Goodrich A, Parveen Z, Dornburg R, Schnell MJ, Pomerantz RJ.

    Mol Ther. 2004 Apr;9(4):557-65.PMID: 15093186 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...